CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsules

Read the official FDA notice

Published
28 Jan 2026
Units affected
22,896 bottles
Agency
FDA
Country
United States

The hazard

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Brand / company
Zydus Pharmaceuticals (USA) Inc
Codes / lots
Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 28 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.